论文部分内容阅读
目的观察培哚普利对心力衰竭的长期治疗效果。方法选取自2010年12月——2012年1月我院收治的心力衰竭患者48例,将这些患者随机分为观察组和对照组各24例,对照组患者给予常规治疗,观察组患者在常规治疗基础上加用培哚普利治疗,随访一年,观察两组的治疗效果。结果三个月内心功能恢复至Ⅱ级以上者,对照组10例,观察组16例,12个月内心功能恢复至Ⅰ级且有不超过一次心衰发作者,对照组8例,观察组13例,对照组2例死于心衰复发,观察组无患者死亡,两组比较差异显著,有统计学意义(P<0.05)。结论培哚普利治疗心力衰竭的长期效果明显,值得临床推广。
Objective To observe the long-term therapeutic effect of perindopril on heart failure. METHODS: Forty-eight patients with heart failure admitted to our hospital from December 2010 to January 2012 were randomly divided into observation group (24 cases) and control group (24 cases). Patients in the control group Perindopril treatment was added on the basis of routine treatment, followed up for one year to observe the therapeutic effect of the two groups. Results Within three months, the cardiac function recovered to level II or higher, the control group of 10 patients and the observation group of 16 patients. Within 12 months, their cardiac function recovered to level I with no more than one heart failure. In the control group, 8 patients and observation group 13 In the control group, 2 patients died of heart failure and no death occurred in the observation group. There was significant difference between the two groups (P <0.05). Conclusion The long-term effect of perindopril in treating heart failure is obvious and worthy of clinical promotion.